PATENT CLAIM ANALYSIS

Application Number: 15986536
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-11
Patent Classification: ["514", "322000"]

Abstract:
The present invention provides methods of administering a PARP inhibitor to a cancer patient.

Claim (Index 112):
The method of  claim 111 , wherein the patient has been treated with the niraparib at an oral daily dose equivalent to 300 mg of niraparib free base for a period of time.

Metadata:
- Claim Count in Document: 86.0
- Percentile: 93.0
- Lexical Diversity: 1.07143
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15852551', '15337274', '15433249', '14772549', '14717069']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7507675386245323
- 35 USC 102 Novelty (BERT): 0.5367130503672982
- Combined Prediction Score: 0.7293620897988089
- Mean Citation Score: 324.554998
- Max Citation Score: 359.90317000000016
- Similarity Product: 220.25273436231083

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test